Immunological Aspects Related to Viral Infections in Severe Asthma and the Role of Omalizumab.

Biomedicines · 2021 · PMC8066139 · PMID 33808197

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a positive trendno p-value reported

The increased production of IFN-α and IFN-λ in 9 out of 10 patients treated with omalizumab for 6 months was statistically significant against influenza virus A, it showed a positive trend versus HRV and it was accompanied by an improvement in control of asthma symptoms [ 57 ].

also in 11,005 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.